THE Dar Rapid Transit (DART), a city council transport franchise, in collaboration with the Africa Carbon Agency, plans to ...
Overall survival at two years was 82.2% in the durvalumab group and 75.2% in the comparator group. Durvalumab (brand name Imfinzi) is a treatment for non small cell lung cancer (NSCLC) but is also ...